Journal article
Real-world patterns of pirfenidone use and safety in patients with idiopathic pulmonary fibrosis in Canada: Data from INSPIRATION PLUS
Abstract
RATIONALE: INSPIRATION PLUS (NCT02552849) was a prospective, observational registry of Canadian patients with idiopathic pulmonary fibrosis (IPF) treated with the oral antifibrotic agent pirfenidone. As an exploratory analysis of the registry, pirfenidone usage and safety were examined in patients with incident pirfenidone use. OBJECTIVE: To describe pirfenidone usage and tolerability in Canadian patients with IPF. METHODS: Patients with IPF …
Authors
Ryerson C; Kolb M; Cox G; Shapera S; Swigris JJ; Fell CD; O’Brien M; Xue C; Rassi J; Moran-Mendoza O
Journal
Canadian Journal of Respiratory Critical Care and Sleep Medicine, Vol. 4, No. 1, pp. 25–30
Publisher
Taylor & Francis
Publication Date
January 2, 2020
DOI
10.1080/24745332.2019.1586496
ISSN
2474-5332